Significant reductions in body weight and improvements in glycaemic control have been demonstrated in early-phase clinical trials, most notably the Phase 2 trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023)
What we know from the broader class is that drinking can be absorbed differently, stomach side effects can stack, and blood sugar can swing
In addition, new drugs such as tirzepatide have come onto the market, expanding the therapeutic options for successful treatment of T2DM and obesity
Compounded semaglutide and tirzepatide from licensed 503A pharmacies meet USP standards and state pharmacy regulations
A little something we call side benefits
In most cases, the doctor will have you finish your current Tirzepatide cycle before beginning Retatrutide